APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell Culture Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cell Culture Service Market Analysis and Forecast 2026-2032

12 August 2026184 pages

Choose your research edition.

Industry ResearchCell Culture Service Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell Culture Service Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Cell Culture Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell Culture Service Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell Culture Service Market Analysis and Forecast 2026-2032184 pages · $4,950 USD

Market perspective

The global Cell Culture Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cell Culture Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cell Culture Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cell Culture Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cell Culture Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cell Culture Service include Danaher, Lonza, WuXi Biologics, Samsung Biologics, Charles River Laboratories, Labcorp Drug Development, Eurofins Scientific, Evotec and Catalent, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cell Culture Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cell Culture Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Cell Culture Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cell Culture Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cell Culture Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cell Culture Service revenue, projected growth trends, production technology, application and end-user industry.

Cell Culture Service Segment by Company

Danaher

Lonza

WuXi Biologics

Samsung Biologics

Charles River Laboratories

Labcorp Drug Development

Eurofins Scientific

Evotec

Catalent

AGC Biologics

ProBioGen

Pharmaron

Takara Bio

AGC Biologics Japan

Thermo Fisher Scientific

Merck KGaA

Sartorius

Cell Culture Service Segment by Type

Primary Cells

Transformed Cells

Self-renewing Cells

Cell Culture Service Segment by Application

Research Institute

Hospital

Others

Cell Culture Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Culture Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell Culture Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Culture Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cell Culture Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cell Culture Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Culture Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell Culture Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Primary Cells Major Player Table 3. Transformed Cells Major Player Table 4. Self-renewing Cells Major Player Table 5. Global Cell Culture Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Research Institute Major Player Table 7. Hospital Major Player Table 8. Others Major Player Table 9. Cell Culture Service Industry Trends Table 10. Cell Culture Service Industry Drivers Table 11. Cell Culture Service Industry Opportunities and Challenges Table 12. Cell Culture Service Industry Restraints Table 13. Global Cell Culture Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Cell Culture Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Cell Culture Service Market Share by Region (2021-2026) Table 16. Global Cell Culture Service Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Cell Culture Service Market Share by Region (2027-2032) Table 18. Global Cell Culture Service Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Cell Culture Service Revenue Market Share by Players (2021-2026) Table 20. Global Cell Culture Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Cell Culture Service Key Players Headquarters & Area Served Table 22. Global Cell Culture Service Players, Product Type & Application Table 23. Global Cell Culture Service Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Cell Culture Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Cell Culture Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Cell Culture Service Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Cell Culture Service Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Cell Culture Service Revenue Market Share by Type (2021-2026) Table 30. Global Cell Culture Service Revenue Market Share by Type (2027-2032) Table 31. Global Cell Culture Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Cell Culture Service Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Cell Culture Service Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Cell Culture Service Revenue Market Share by Application (2021-2026) Table 35. Global Cell Culture Service Revenue Market Share by Application (2027-2032) Table 36. Danaher Company Information Table 37. Danaher Business Overview Table 38. Danaher Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Danaher Cell Culture Service Product Portfolio Table 40. Danaher Recent Development Table 41. Lonza Company Information Table 42. Lonza Business Overview Table 43. Lonza Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Lonza Cell Culture Service Product Portfolio Table 45. Lonza Recent Development Table 46. WuXi Biologics Company Information Table 47. WuXi Biologics Business Overview Table 48. WuXi Biologics Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. WuXi Biologics Cell Culture Service Product Portfolio Table 50. WuXi Biologics Recent Development Table 51. Samsung Biologics Company Information Table 52. Samsung Biologics Business Overview Table 53. Samsung Biologics Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Samsung Biologics Cell Culture Service Product Portfolio Table 55. Samsung Biologics Recent Development Table 56. Charles River Laboratories Company Information Table 57. Charles River Laboratories Business Overview Table 58. Charles River Laboratories Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Charles River Laboratories Cell Culture Service Product Portfolio Table 60. Charles River Laboratories Recent Development Table 61. Labcorp Drug Development Company Information Table 62. Labcorp Drug Development Business Overview Table 63. Labcorp Drug Development Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Labcorp Drug Development Cell Culture Service Product Portfolio Table 65. Labcorp Drug Development Recent Development Table 66. Eurofins Scientific Company Information Table 67. Eurofins Scientific Business Overview Table 68. Eurofins Scientific Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Eurofins Scientific Cell Culture Service Product Portfolio Table 70. Eurofins Scientific Recent Development Table 71. Evotec Company Information Table 72. Evotec Business Overview Table 73. Evotec Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Evotec Cell Culture Service Product Portfolio Table 75. Evotec Recent Development Table 76. Catalent Company Information Table 77. Catalent Business Overview Table 78. Catalent Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Catalent Cell Culture Service Product Portfolio Table 80. Catalent Recent Development Table 81. AGC Biologics Company Information Table 82. AGC Biologics Business Overview Table 83. AGC Biologics Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. AGC Biologics Cell Culture Service Product Portfolio Table 85. AGC Biologics Recent Development Table 86. ProBioGen Company Information Table 87. ProBioGen Business Overview Table 88. ProBioGen Cell Culture Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. ProBioGen Cell Culture Service Product Portfolio Table 90. ProBioGen Recent Development Table 91. Pharmaron Company Information Table 92. Pharmaron Business Overview Table 93. Pharmaron Cell Culture Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Pharmaron Cell Culture Service Product Portfolio Table 95. Pharmaron Recent Development Table 96. Takara Bio Company Information Table 97. Takara Bio Business Overview Table 98. Takara Bio Cell Culture Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Takara Bio Cell Culture Service Product Portfolio Table 100. Takara Bio Recent Development Table 101. AGC Biologics Japan Company Information Table 102. AGC Biologics Japan Business Overview Table 103. AGC Biologics Japan Cell Culture Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. AGC Biologics Japan Cell Culture Service Product Portfolio Table 105. AGC Biologics Japan Recent Development Table 106. Thermo Fisher Scientific Company Information Table 107. Thermo Fisher Scientific Business Overview Table 108. Thermo Fisher Scientific Cell Culture Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Thermo Fisher Scientific Cell Culture Service Product Portfolio Table 110. Thermo Fisher Scientific Recent Development Table 111. Merck KGaA Company Information Table 112. Merck KGaA Business Overview Table 113. Merck KGaA Cell Culture Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Merck KGaA Cell Culture Service Product Portfolio Table 115. Merck KGaA Recent Development Table 116. Sartorius Company Information Table 117. Sartorius Business Overview Table 118. Sartorius Cell Culture Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Sartorius Cell Culture Service Product Portfolio Table 120. Sartorius Recent Development Table 121. North America Cell Culture Service Revenue by Type (2021-2026) & (US$ Million) Table 122. North America Cell Culture Service Revenue by Type (2027-2032) & (US$ Million) Table 123. North America Cell Culture Service Revenue by Application (2021-2026) & (US$ Million) Table 124. North America Cell Culture Service Revenue by Application (2027-2032) & (US$ Million) Table 125. North America Cell Culture Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Cell Culture Service Revenue by Country (2021-2026) & (US$ Million) Table 127. North America Cell Culture Service Revenue by Country (US$ Million) & (2027-2032) Table 128. Europe Cell Culture Service Revenue by Type (2021-2026) & (US$ Million) Table 129. Europe Cell Culture Service Revenue by Type (2027-2032) & (US$ Million) Table 130. Europe Cell Culture Service Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Cell Culture Service Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Cell Culture Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Cell Culture Service Revenue by Country (2021-2026) & (US$ Million) Table 134. Europe Cell Culture Service Revenue by Country (US$ Million) & (2027-2032) Table 135. China Cell Culture Service Revenue by Type (2021-2026) & (US$ Million) Table 136. China Cell Culture Service Revenue by Type (2027-2032) & (US$ Million) Table 137. China Cell Culture Service Revenue by Application (2021-2026) & (US$ Million) Table 138. China Cell Culture Service Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Cell Culture Service Revenue by Type (2021-2026) & (US$ Million) Table 140. Asia Cell Culture Service Revenue by Type (2027-2032) & (US$ Million) Table 141. Asia Cell Culture Service Revenue by Application (2021-2026) & (US$ Million) Table 142. Asia Cell Culture Service Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia Cell Culture Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia Cell Culture Service Revenue by Region (US$ Million) & (2021-2026) Table 145. Asia Cell Culture Service Revenue by Region (US$ Million) & (2027-2032) Table 146. SAMEA Cell Culture Service Revenue by Type (2021-2026) & (US$ Million) Table 147. SAMEA Cell Culture Service Revenue by Type (2027-2032) & (US$ Million) Table 148. SAMEA Cell Culture Service Revenue by Application (2021-2026) & (US$ Million) Table 149. SAMEA Cell Culture Service Revenue by Application (2027-2032) & (US$ Million) Table 150. SAMEA Cell Culture Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. SAMEA Cell Culture Service Revenue by Country (2021-2026) & (US$ Million) Table 152. SAMEA Cell Culture Service Revenue by Country (US$ Million) & (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Cell Culture Service Image Figure 2. Global Cell Culture Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell Culture Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Primary Cells Image Figure 5. Transformed Cells Image Figure 6. Self-renewing Cells Image Figure 7. Global Cell Culture Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Cell Culture Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Research Institute Image Figure 10. Hospital Image Figure 11. Others Image Figure 12. Global Cell Culture Service Market Size (US$ Million) & (2021-2032) Figure 13. Global Cell Culture Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Cell Culture Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Cell Culture Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Cell Culture Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Cell Culture Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Cell Culture Service Revenue Market Share by Type (2021-2032) Figure 20. Global Cell Culture Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Cell Culture Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Cell Culture Service Revenue Market Share by Application (2021-2032) Figure 23. North America Cell Culture Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Cell Culture Service Revenue Share by Type (2021-2032) Figure 25. North America Cell Culture Service Revenue Share by Application (2021-2032) Figure 26. North America Cell Culture Service Revenue Share by Country (2021-2032) Figure 27. United States Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Cell Culture Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Cell Culture Service Revenue Share by Type (2021-2032) Figure 32. Europe Cell Culture Service Revenue Share by Application (2021-2032) Figure 33. Europe Cell Culture Service Revenue Share by Country (2021-2032) Figure 34. Germany Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Cell Culture Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Cell Culture Service Revenue Share by Type (2021-2032) Figure 44. China Cell Culture Service Revenue Share by Application (2021-2032) Figure 45. Asia Cell Culture Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Cell Culture Service Revenue Share by Type (2021-2032) Figure 47. Asia Cell Culture Service Revenue Share by Application (2021-2032) Figure 48. Asia Cell Culture Service Revenue Share by Region (2021-2032) Figure 49. Japan Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Cell Culture Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Cell Culture Service Revenue Share by Type (2021-2032) Figure 57. SAMEA Cell Culture Service Revenue Share by Application (2021-2032) Figure 58. SAMEA Cell Culture Service Revenue Share by Country (2021-2032) Figure 59. Brazil Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Cell Culture Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Primary Cells
  • Transformed Cells
  • Self-renewing Cells
Applications
  • Research Institute
  • Hospital
  • Others
Companies covered
  • Danaher
  • Lonza
  • WuXi Biologics
  • Samsung Biologics
  • Charles River Laboratories
  • Labcorp Drug Development
  • Eurofins Scientific
  • Evotec
  • Catalent
  • AGC Biologics
  • ProBioGen
  • Pharmaron
  • Takara Bio
  • AGC Biologics Japan
  • Thermo Fisher Scientific
  • Merck KGaA
  • Sartorius

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cell Culture Service Market by Type
  3. 1.2.1 Global Cell Culture Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Primary Cells
  5. 1.2.3 Transformed Cells
  6. 1.2.4 Self-renewing Cells
  7. 1.3 Cell Culture Service Market by Application
  8. 1.3.1 Global Cell Culture Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Research Institute
  10. 1.3.3 Hospital
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Cell Culture Service Market Dynamics
  1. 2.1 Cell Culture Service Industry Trends
  2. 2.2 Cell Culture Service Industry Drivers
  3. 2.3 Cell Culture Service Industry Opportunities and Challenges
  4. 2.4 Cell Culture Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cell Culture Service Market Perspective (2021-2032)
  2. 3.2 Global Cell Culture Service Growth Trends by Region
  3. 3.2.1 Global Cell Culture Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cell Culture Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Cell Culture Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cell Culture Service Revenue by Players
  2. 4.1.1 Global Cell Culture Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Cell Culture Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cell Culture Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cell Culture Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cell Culture Service Key Players Headquarters & Area Served
  7. 4.4 Global Cell Culture Service Players, Product Type & Application
  8. 4.5 Global Cell Culture Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cell Culture Service Market CR5 and HHI
  11. 4.6.3 2025 Cell Culture Service Tier 1, Tier 2, and Tier 3
5 Cell Culture Service Market Size by Type
  1. 5.1 Global Cell Culture Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell Culture Service Revenue by Type (2021-2032)
  3. 5.3 Global Cell Culture Service Revenue Market Share by Type (2021-2032)
6 Cell Culture Service Market Size by Application
  1. 6.1 Global Cell Culture Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cell Culture Service Revenue by Application (2021-2032)
  3. 6.3 Global Cell Culture Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Danaher
  2. 7.1.1 Danaher Company Information
  3. 7.1.2 Danaher Business Overview
  4. 7.1.3 Danaher Cell Culture Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Danaher Cell Culture Service Product Portfolio
  6. 7.1.5 Danaher Recent Developments
  7. 7.2 Lonza
  8. 7.2.1 Lonza Company Information
  9. 7.2.2 Lonza Business Overview
  10. 7.2.3 Lonza Cell Culture Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Lonza Cell Culture Service Product Portfolio
  12. 7.2.5 Lonza Recent Developments
  13. 7.3 WuXi Biologics
  14. 7.3.1 WuXi Biologics Company Information
  15. 7.3.2 WuXi Biologics Business Overview
  16. 7.3.3 WuXi Biologics Cell Culture Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 WuXi Biologics Cell Culture Service Product Portfolio
  18. 7.3.5 WuXi Biologics Recent Developments
  19. 7.4 Samsung Biologics
  20. 7.4.1 Samsung Biologics Company Information
  21. 7.4.2 Samsung Biologics Business Overview
  22. 7.4.3 Samsung Biologics Cell Culture Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Samsung Biologics Cell Culture Service Product Portfolio
  24. 7.4.5 Samsung Biologics Recent Developments
  25. 7.5 Charles River Laboratories
  26. 7.5.1 Charles River Laboratories Company Information
  27. 7.5.2 Charles River Laboratories Business Overview
  28. 7.5.3 Charles River Laboratories Cell Culture Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Charles River Laboratories Cell Culture Service Product Portfolio
  30. 7.5.5 Charles River Laboratories Recent Developments
  31. 7.6 Labcorp Drug Development
  32. 7.6.1 Labcorp Drug Development Company Information
  33. 7.6.2 Labcorp Drug Development Business Overview
  34. 7.6.3 Labcorp Drug Development Cell Culture Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Labcorp Drug Development Cell Culture Service Product Portfolio
  36. 7.6.5 Labcorp Drug Development Recent Developments
  37. 7.7 Eurofins Scientific
  38. 7.7.1 Eurofins Scientific Company Information
  39. 7.7.2 Eurofins Scientific Business Overview
  40. 7.7.3 Eurofins Scientific Cell Culture Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Eurofins Scientific Cell Culture Service Product Portfolio
  42. 7.7.5 Eurofins Scientific Recent Developments
  43. 7.8 Evotec
  44. 7.8.1 Evotec Company Information
  45. 7.8.2 Evotec Business Overview
  46. 7.8.3 Evotec Cell Culture Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Evotec Cell Culture Service Product Portfolio
  48. 7.8.5 Evotec Recent Developments
  49. 7.9 Catalent
  50. 7.9.1 Catalent Company Information
  51. 7.9.2 Catalent Business Overview
  52. 7.9.3 Catalent Cell Culture Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Catalent Cell Culture Service Product Portfolio
  54. 7.9.5 Catalent Recent Developments
  55. 7.10 AGC Biologics
  56. 7.10.1 AGC Biologics Company Information
  57. 7.10.2 AGC Biologics Business Overview
  58. 7.10.3 AGC Biologics Cell Culture Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 AGC Biologics Cell Culture Service Product Portfolio
  60. 7.10.5 AGC Biologics Recent Developments
  61. 7.11 ProBioGen
  62. 7.11.1 ProBioGen Company Information
  63. 7.11.2 ProBioGen Business Overview
  64. 7.11.3 ProBioGen Cell Culture Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 ProBioGen Cell Culture Service Product Portfolio
  66. 7.11.5 ProBioGen Recent Developments
  67. 7.12 Pharmaron
  68. 7.12.1 Pharmaron Company Information
  69. 7.12.2 Pharmaron Business Overview
  70. 7.12.3 Pharmaron Cell Culture Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Pharmaron Cell Culture Service Product Portfolio
  72. 7.12.5 Pharmaron Recent Developments
  73. 7.13 Takara Bio
  74. 7.13.1 Takara Bio Company Information
  75. 7.13.2 Takara Bio Business Overview
  76. 7.13.3 Takara Bio Cell Culture Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Takara Bio Cell Culture Service Product Portfolio
  78. 7.13.5 Takara Bio Recent Developments
  79. 7.14 AGC Biologics Japan
  80. 7.14.1 AGC Biologics Japan Company Information
  81. 7.14.2 AGC Biologics Japan Business Overview
  82. 7.14.3 AGC Biologics Japan Cell Culture Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 AGC Biologics Japan Cell Culture Service Product Portfolio
  84. 7.14.5 AGC Biologics Japan Recent Developments
  85. 7.15 Thermo Fisher Scientific
  86. 7.15.1 Thermo Fisher Scientific Company Information
  87. 7.15.2 Thermo Fisher Scientific Business Overview
  88. 7.15.3 Thermo Fisher Scientific Cell Culture Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Thermo Fisher Scientific Cell Culture Service Product Portfolio
  90. 7.15.5 Thermo Fisher Scientific Recent Developments
  91. 7.16 Merck KGaA
  92. 7.16.1 Merck KGaA Company Information
  93. 7.16.2 Merck KGaA Business Overview
  94. 7.16.3 Merck KGaA Cell Culture Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Merck KGaA Cell Culture Service Product Portfolio
  96. 7.16.5 Merck KGaA Recent Developments
  97. 7.17 Sartorius
  98. 7.17.1 Sartorius Company Information
  99. 7.17.2 Sartorius Business Overview
  100. 7.17.3 Sartorius Cell Culture Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Sartorius Cell Culture Service Product Portfolio
  102. 7.17.5 Sartorius Recent Developments
8 North America
  1. 8.1 North America Cell Culture Service Revenue (2021-2032)
  2. 8.2 North America Cell Culture Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Cell Culture Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Cell Culture Service Revenue by Type (2027-2032)
  5. 8.3 North America Cell Culture Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Cell Culture Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Cell Culture Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Cell Culture Service Revenue by Application (2027-2032)
  9. 8.5 North America Cell Culture Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Cell Culture Service Revenue by Country
  11. 8.6.1 North America Cell Culture Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cell Culture Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Cell Culture Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cell Culture Service Revenue (2021-2032)
  2. 9.2 Europe Cell Culture Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cell Culture Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cell Culture Service Revenue by Type (2027-2032)
  5. 9.3 Europe Cell Culture Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cell Culture Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cell Culture Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cell Culture Service Revenue by Application (2027-2032)
  9. 9.5 Europe Cell Culture Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cell Culture Service Revenue by Country
  11. 9.6.1 Europe Cell Culture Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cell Culture Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cell Culture Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cell Culture Service Revenue (2021-2032)
  2. 10.2 China Cell Culture Service Revenue by Type (2021-2032)
  3. 10.2.1 China Cell Culture Service Revenue by Type (2021-2026)
  4. 10.2.2 China Cell Culture Service Revenue by Type (2027-2032)
  5. 10.3 China Cell Culture Service Revenue Share by Type (2021-2032)
  6. 10.4 China Cell Culture Service Revenue by Application (2021-2032)
  7. 10.4.1 China Cell Culture Service Revenue by Application (2021-2026)
  8. 10.4.2 China Cell Culture Service Revenue by Application (2027-2032)
  9. 10.5 China Cell Culture Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cell Culture Service Revenue (2021-2032)
  2. 11.2 Asia Cell Culture Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cell Culture Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cell Culture Service Revenue by Type (2027-2032)
  5. 11.3 Asia Cell Culture Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cell Culture Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cell Culture Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cell Culture Service Revenue by Application (2027-2032)
  9. 11.5 Asia Cell Culture Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cell Culture Service Revenue by Country
  11. 11.6.1 Asia Cell Culture Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cell Culture Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cell Culture Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cell Culture Service Revenue (2021-2032)
  2. 12.2 SAMEA Cell Culture Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cell Culture Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cell Culture Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cell Culture Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cell Culture Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cell Culture Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cell Culture Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cell Culture Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cell Culture Service Revenue by Country
  11. 12.6.1 SAMEA Cell Culture Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cell Culture Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cell Culture Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst